S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Nektar Therapeutics (NKTR) News Today

$0.78
+0.07 (+9.86%)
(As of 03/1/2024 ET)
SourceHeadline
markets.businessinsider.com logoNektar Therapeutics earnings: here's what Wall Street expects
markets.businessinsider.com - March 3 at 10:01 AM
MarketBeat logoNektar Therapeutics (NKTR) Set to Announce Quarterly Earnings on Monday
americanbankingnews.com - March 2 at 1:18 AM
benzinga.com logoNektar Therapeutics Earnings Preview
benzinga.com - March 1 at 11:43 AM
prnewswire.com logoNektar Management to Present at the TD Cowen 44th Annual Health Care Conference
prnewswire.com - February 27 at 6:00 PM
marketbeat.com logoLynx1 Capital Management LP Takes $1.05 Million Position in Nektar Therapeutics (NASDAQ:NKTR)
marketbeat.com - February 27 at 3:43 PM
prnewswire.com logoNektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
prnewswire.com - February 26 at 6:00 PM
marketbeat.com logoAcadian Asset Management LLC Acquires 3,230,368 Shares of Nektar Therapeutics (NASDAQ:NKTR)
marketbeat.com - February 24 at 6:45 AM
msn.com logoNektar to play final UK live show at Nene Valley Rock festival in September
msn.com - February 23 at 7:09 PM
msn.com logoEuro zone bond yields dip, data shows wage growth slowed in Q4
msn.com - February 22 at 3:28 PM
benzinga.com logoNektar Therapeutics Stock (NASDAQ:NKTR) Insider Trades
benzinga.com - February 22 at 10:28 AM
finance.yahoo.com logoWill Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know
finance.yahoo.com - February 20 at 3:42 PM
marketbeat.com logoEquities Analysts Offer Predictions for Nektar Therapeutics' Q1 2024 Earnings (NASDAQ:NKTR)
marketbeat.com - February 19 at 1:35 AM
marketbeat.com logoNektar Therapeutics (NASDAQ:NKTR) Receives Average Rating of "Reduce" from Analysts
marketbeat.com - February 9 at 1:33 AM
finance.yahoo.com logoDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
finance.yahoo.com - January 22 at 8:54 AM
markets.businessinsider.com logoDiaMedica Appoints Lorianne Masuoka As Chief Medical Officer
markets.businessinsider.com - January 22 at 8:54 AM
marketbeat.com logoNektar Therapeutics (NASDAQ:NKTR) Short Interest Update
marketbeat.com - January 14 at 7:19 AM
finance.yahoo.com logoNektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
finance.yahoo.com - January 3 at 6:13 PM
finance.yahoo.com logoFollowing a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR) institutional owners
finance.yahoo.com - December 30 at 12:56 PM
ca.finance.yahoo.com logoNektar Therapeutics (NKTR) Latest Stock News & Headlines - Yahoo Finance
ca.finance.yahoo.com - December 21 at 3:03 PM
finance.yahoo.com logoNektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 11 at 6:08 PM
finance.yahoo.com logoNektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - December 7 at 1:43 PM
benzinga.com logoNektar Therapeutics Stock (NASDAQ:NKTR) Earnings Dates and Earning Calls
benzinga.com - November 10 at 12:59 AM
markets.businessinsider.com logoPositive Report for Nektar Therapeutics (NKTR) from TD Cowen
markets.businessinsider.com - November 10 at 12:59 AM
msn.com logoTD Cowen Upgrades Nektar Therapeutics (NKTR)
msn.com - November 10 at 12:59 AM
finance.yahoo.com logoNektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 9 at 9:57 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS) and Nektar Therapeutics (NKTR)
markets.businessinsider.com - November 8 at 7:06 PM
finance.yahoo.com logoNektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Loss
finance.yahoo.com - November 8 at 2:06 PM
benzinga.com logoRecap: Nektar Therapeutics Q3 Earnings
benzinga.com - November 7 at 7:56 PM
markets.businessinsider.com logoNektar Therapeutics Q3 Loss decreases, but misses estimates
markets.businessinsider.com - November 7 at 7:56 PM
benzinga.com logoA Preview Of Nektar Therapeutics's Earnings
benzinga.com - November 6 at 6:43 PM
finance.yahoo.com logoNektar to Announce Financial Results for the Third Quarter 2023 on Tuesday, November 7, 2023, After Close of U.S.-Based Financial Markets
finance.yahoo.com - October 31 at 8:59 PM
finance.yahoo.com logoNektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress
finance.yahoo.com - October 13 at 10:16 AM
msn.com logoNektar Therapeutics (NKTR) Price Target Increased by 22.34% to 2.93
msn.com - October 5 at 10:07 AM
finance.yahoo.com logoNektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy
finance.yahoo.com - October 2 at 9:28 AM
finance.yahoo.com logoNektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer
finance.yahoo.com - September 27 at 12:32 PM
benzinga.com logoDirector at Nektar Therapeutics Acquires Company Stock Options Worth 85,000 Shares
benzinga.com - September 21 at 12:16 PM
benzinga.com logoNektar Therapeutics Board Member Awarded $59K Worth of Stock Options
benzinga.com - September 21 at 12:16 PM
markets.businessinsider.com logoNektar Therapeutics Reports Promising Data From Phase 1b Study Of Rezpegaldesleukin
markets.businessinsider.com - September 13 at 3:43 PM
marketbeat.com logoNektar Therapeutics (NASDAQ:NKTR) Receives Consensus Recommendation of "Reduce" from Analysts
marketbeat.com - September 12 at 2:55 AM
finance.yahoo.com logoWhy Is Nektar (NKTR) Down 37.1% Since Last Earnings Report?
finance.yahoo.com - September 7 at 5:37 PM
marketbeat.com logoAcadian Asset Management LLC Raises Stake in Nektar Therapeutics (NASDAQ:NKTR)
marketbeat.com - September 7 at 5:23 AM
finance.yahoo.com logoNektar Therapeutics to Host Virtual Investor & Analyst Event with Dermatology Experts on September 13th
finance.yahoo.com - September 6 at 6:15 PM
marketbeat.com logoNektar Therapeutics (NASDAQ:NKTR) Holdings Raised by Connor Clark & Lunn Investment Management Ltd.
marketbeat.com - August 27 at 4:53 AM
marketbeat.com logoNektar Therapeutics (NASDAQ:NKTR) Holdings Raised by Connor Clark & Lunn Investment Management Ltd.
marketbeat.com - August 27 at 4:53 AM
marketbeat.com logoQ3 2023 EPS Estimates for Nektar Therapeutics (NASDAQ:NKTR) Decreased by Zacks Research
marketbeat.com - August 25 at 5:53 AM
gurufocus.com logoRA Capital Management, L.P. Acquires Significant Stake in Nektar Therapeutics
gurufocus.com - August 18 at 3:01 AM
marketbeat.com logoSG Americas Securities LLC Purchases 132,478 Shares of Nektar Therapeutics (NASDAQ:NKTR)
marketbeat.com - August 15 at 4:36 AM
marketbeat.com logoFY2023 EPS Estimates for Nektar Therapeutics Boosted by William Blair (NASDAQ:NKTR)
marketbeat.com - August 11 at 10:00 AM
finance.yahoo.com logoNektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss
finance.yahoo.com - August 9 at 2:41 PM
markets.businessinsider.com logoNektar Therapeutics Q2 Loss decreases, beats estimates
markets.businessinsider.com - August 8 at 6:21 PM
Get Nektar Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter.



NKTR Media Mentions By Week

NKTR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NKTR
News Sentiment

0.57

0.65

Average
Medical
News Sentiment

NKTR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NKTR Articles
This Week

8

2

NKTR Articles
Average Week

Get Nektar Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NKTR) was last updated on 3/3/2024 by MarketBeat.com Staff